Intellia Therapeutics
Kutralanathan Renganathan is an accomplished professional in the biotechnology and pharmaceutical industries, currently serving as Director and previously as Associate Director at Intellia Therapeutics, Inc. Prior experience includes roles as Principal Scientist, Senior Scientist, and Scientist at Momenta Pharmaceuticals, as well as Research Scientist at ITSI Biosciences. Kutralanathan began academic contributions as a Postdoctoral Fellow at the University of Colorado and completed a Doctoral degree at Cleveland Clinic. Academic credentials include a PhD in Chemistry from Case Western Reserve University and a Master's in Chemistry from Eastern Michigan University.
This person is not in any teams
Intellia Therapeutics
9 followers
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.